Barker, E, Fujimura, S F, Fadem, M B et al. · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 1994 · DOI
This study examined immune cells in the blood of ME/CFS patients and compared them to healthy people. Researchers found that ME/CFS patients had normal numbers of immune cells overall, but the cells showed signs of being overactive and tired. Most notably, patients had significantly reduced natural killer cell activity—these are immune cells that normally help fight infections and abnormal cells.
This study provided early evidence that ME/CFS involves measurable immune dysfunction, particularly NK cell impairment, which helps validate that the illness has a biological basis. Understanding these immune abnormalities has guided subsequent research into whether immune system dysregulation drives ME/CFS symptoms and could inform future therapeutic approaches targeting immune restoration.
This study documents immune cell abnormalities in CFS patients but does not establish whether these changes cause ME/CFS symptoms, result from the illness, or are merely associated with it. It also does not explain what triggers these immune changes or whether correcting them would improve patient outcomes. The cross-sectional design cannot establish temporal relationships or causality.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.